Fulgent Genetics, Inc. Quarterly Common Stock, Shares, Issued from Q3 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Fulgent Genetics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q3 2016 to Q3 2024.
  • Fulgent Genetics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 33.3M shares, a 4.34% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 33.3M +1.39M +4.34% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 33M +1.31M +4.12% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 32.7M +1.16M +3.69% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 32.4M +1.17M +3.74% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 31.9M +1.25M +4.07% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 31.7M +1.25M +4.09% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 31.5M +1.18M +3.87% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 31.2M +1.09M +3.61% Dec 31, 2022 10-K 2024-02-28
Q3 2022 30.7M +848K +2.84% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 30.5M +968K +3.28% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 30.3M +1.34M +4.62% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 30.2M +1.98M +7.03% Dec 31, 2021 10-K 2023-02-28
Q3 2021 29.8M +6.52M +28% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 29.5M +7.7M +35.3% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 29M +7.32M +33.8% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 28.2M +6.7M +31.2% Dec 31, 2020 10-K 2022-02-28
Q3 2020 23.3M +4.63M +24.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 21.8M +3.42M +18.6% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 21.7M +3.39M +18.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 21.5M +3.31M +18.2% Dec 31, 2019 10-K 2021-03-08
Q3 2019 18.7M +616K +3.41% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 18.4M +430K +2.39% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 18.3M +410K +2.29% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 18.2M +325K +1.82% Dec 31, 2018 10-K 2020-03-13
Q3 2018 18.1M +286K +1.61% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 18M +223K +1.26% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 17.9M +195K +1.1% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 17.8M +171K +0.97% Dec 31, 2017 10-K 2019-03-22
Q3 2017 17.8M +4.93M +38.3% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 17.7M Jun 30, 2017 10-Q 2017-08-14
Q1 2017 17.7M Mar 31, 2017 10-Q 2017-05-09
Q4 2016 17.7M Dec 31, 2016 10-K 2018-03-20
Q3 2016 12.8M Sep 30, 2016 10-Q 2016-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.